Synovial Fluid and Serum MicroRNA Signatures in Equine Osteoarthritis
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262211190 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Catarina I G D Castanheira und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Musculoskeletal and Ageing Research, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool L7 8TX, UK. Hauptthemen laut MEDLINE: Osteoarthritis, Synovial Fluid, MicroRNAs, Horse Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council, The Horse Trust.
Abstract (Originalsprache)
The aim of this study was to identify differentially expressed microRNAs (miRNAs) in serum and synovial fluid (SF) samples of control horses and those with osteoarthritis (OA) to identify potential candidates for biomarkers of disease. Total RNA was extracted from serum and SF samples of control (n = 4) and OA (n = 9) horses and sequenced. Differential expression analysis, pathway analysis and miRNA target prediction were performed. A group of six miRNAs (eca-miR-199a-3p, eca-miR-148a, eca-miR-99b, eca-miR-146a, eca-miR-423-5p and eca-miR-23b) was selected for validation in an independent cohort (serum, n = 46; SF, n = 88). The effect of clinical variables on miRNA expression was also assessed. Sequencing analyses found 43 and 23 differentially expressed miRNAs in serum and SF samples, respectively. Pathway analysis showed miRNAs were involved in inflammatory disease/response and associated with OA pathways. miRNA expression in serum was strongly associated with the horses’ workload, while age had a pronounced influence on miRNA expression in SF. Distinct patterns of miRNA differential expression were observed in serum and SF samples from horses with OA compared to controls. miR-199a-3p and miR-148a warrant further investigation as potential biomarkers of equine OA. Further characterization of these molecular changes could provide novel insights into the mechanisms of early OA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Musculoskeletal and Ageing Research, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool L7 8TX, UK.
- The Royal (Dick) School of Veterinary Studies, The Roslin Institute, University of Edinburgh, Edinburgh EH8 9YL, UK.
- Swedish University of Agricultural Sciences, SE-750 07 Uppsala, Sweden.
- Sussex Equine Hospital, Billingshurst Road, Ashington RH20 3BB, UK.
- TAmiRNA GmbH, Ltd., 1110 Vienna, Austria.
ORCID-Profile: Sarah Taylor, Eva Skiöldebrand, Mandy J Peffers
Förderung
- Wellcome Trust
- Medical Research Council
- The Horse Trust
Zitieren
APA
Castanheira, C. I. G. D., Taylor, S., Skiöldebrand, E., Rubio-Martinez, L. M., Hackl, M., Clegg, P. D., & Peffers, M. J. (2025). Synovial Fluid and Serum MicroRNA Signatures in Equine Osteoarthritis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262211190
Vancouver
Castanheira CIGD, Taylor S, Skiöldebrand E, Rubio-Martinez LM, Hackl M, Clegg PD, et al. Synovial Fluid and Serum MicroRNA Signatures in Equine Osteoarthritis. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262211190
BibTeX
@article{Castanheira2025,
author = {Castanheira, Catarina I G D and Taylor, Sarah and Skiöldebrand, Eva and Rubio-Martinez, Luis M and Hackl, Matthias and Clegg, Peter D and Peffers, Mandy J},
title = {Synovial Fluid and Serum MicroRNA Signatures in Equine Osteoarthritis},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262211190}
}
EUVIMED